tiprankstipranks
Bio-Rad Laboratories (BIO)
NYSE:BIO
US Market
BIO
Bio-Rad Laboratories
RESEARCH TOOLSreports
Want to see BIO full AI Analyst Report?

Bio-Rad Laboratories (BIO) Ratios

924 Followers

Bio-Rad Laboratories Ratios

BIO's free cash flow for Q1 2026 was $0.52. For the 2026 fiscal year, BIO's free cash flow was decreased by $ and operating cash flow was $-1.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.21 5.62 6.48 5.83 5.55
Quick Ratio
 3.21 4.19 4.85 4.34 4.29
Cash Ratio
 0.55 1.03 1.04 0.77 0.76
Solvency Ratio
 0.11 0.31 -0.61 -0.14 -0.89
Operating Cash Flow Ratio
 0.56 1.03 0.97 0.72 0.34
Short-Term Operating Cash Flow Coverage
 1.17 14.04 379.33 749.89 418.17
Net Current Asset Value
$ 3.40M$ -216.70M$ 235.50M$ -509.60M$ -728.44M
Leverage Ratios
Debt-to-Assets Ratio
 0.14 0.14 0.15 0.11 0.10
Debt-to-Equity Ratio
 0.20 0.21 0.21 0.16 0.14
Debt-to-Capital Ratio
 0.17 0.17 0.17 0.14 0.13
Long-Term Debt-to-Capital Ratio
 0.10 0.15 0.15 0.12 0.11
Financial Leverage Ratio
 1.43 1.42 1.43 1.41 1.40
Debt Service Coverage Ratio
 -0.04 2.77 -32.81 -8.85 -88.45
Interest Coverage Ratio
 4.86 5.52 5.50 6.83 12.66
Debt to Market Cap
 0.16 0.17 0.13 0.13 0.10
Interest Debt Per Share
 52.95 57.95 50.46 49.81 47.88
Net Debt to EBITDA
 25.17 2.10 -0.41 -1.53 -0.21
Profitability Margins
Gross Profit Margin
51.87%52.01%53.73%53.42%55.93%
EBIT Margin
-4.73%10.47%-89.37%-29.97%-166.51%
EBITDA Margin
1.34%18.42%-83.46%-24.51%-160.19%
Operating Profit Margin
9.25%10.47%10.48%12.65%17.22%
Pretax Profit Margin
8.58%38.54%-91.27%-31.82%-167.87%
Net Profit Margin
6.52%29.42%-71.86%-23.86%-129.45%
Continuous Operations Profit Margin
6.52%29.42%-71.86%-23.86%-129.45%
Net Income Per EBT
75.93%76.33%78.73%74.97%77.11%
EBT Per EBIT
92.82%368.02%-870.82%-251.66%-974.74%
Return on Assets (ROA)
1.72%7.18%-19.69%-5.18%-26.87%
Return on Equity (ROE)
2.40%10.20%-28.07%-7.29%-37.73%
Return on Capital Employed (ROCE)
2.70%2.69%3.02%2.87%3.73%
Return on Invested Capital (ROIC)
1.95%2.04%2.37%2.14%2.87%
Return on Tangible Assets
1.87%7.74%-21.30%-5.51%-28.42%
Earnings Yield
2.18%9.20%-19.90%-6.76%-28.96%
Efficiency Ratios
Receivables Turnover
 5.89 5.47 5.67 5.46 5.67
Payables Turnover
 9.37 9.61 9.71 8.61 9.14
Inventory Turnover
 0.00 1.67 1.56 1.59 1.72
Fixed Asset Turnover
 0.00 3.64 3.73 3.69 4.12
Asset Turnover
 0.26 0.24 0.27 0.22 0.21
Working Capital Turnover Ratio
 1.17 1.04 1.01 1.04 1.44
Cash Conversion Cycle
 22.97 246.88 260.35 253.35 237.12
Days of Sales Outstanding
 61.94 66.76 64.35 66.82 64.43
Days of Inventory Outstanding
 0.00 218.10 233.58 228.95 212.61
Days of Payables Outstanding
 38.97 37.98 37.59 42.42 39.91
Operating Cycle
 61.94 284.86 297.93 295.76 277.03
Cash Flow Ratios
Operating Cash Flow Per Share
 18.93 19.52 16.13 12.84 6.53
Free Cash Flow Per Share
 13.25 13.74 9.44 7.47 2.70
CapEx Per Share
 5.68 5.78 6.70 5.36 3.83
Free Cash Flow to Operating Cash Flow
 0.70 0.70 0.58 0.58 0.41
Dividend Paid and CapEx Coverage Ratio
 2.74 3.38 2.41 2.39 1.70
Capital Expenditure Coverage Ratio
 3.33 3.38 2.41 2.39 1.70
Operating Cash Flow Coverage Ratio
 0.37 0.35 0.33 0.27 0.14
Operating Cash Flow to Sales Ratio
 0.20 0.21 0.18 0.14 0.07
Free Cash Flow Yield
4.61%4.53%2.87%2.31%0.64%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 45.79 10.87 -5.03 -14.80 -3.45
Price-to-Sales (P/S) Ratio
 2.99 3.20 3.61 3.53 4.47
Price-to-Book (P/B) Ratio
 1.13 1.11 1.41 1.08 1.30
Price-to-Free Cash Flow (P/FCF) Ratio
 21.70 22.05 34.82 43.21 155.99
Price-to-Operating Cash Flow Ratio
 15.14 15.52 20.36 25.15 64.41
Price-to-Earnings Growth (PEG) Ratio
 -0.11 -0.08 -0.03 0.18 0.02
Price-to-Fair Value
 1.13 1.11 1.41 1.08 1.30
Enterprise Value Multiple
 249.22 19.46 -4.74 -15.93 -3.00
Enterprise Value
 8.62B 9.26B 10.16B 10.43B 13.48B
EV to EBITDA
 249.22 19.46 -4.74 -15.93 -3.00
EV to Sales
 3.33 3.58 3.96 3.91 4.81
EV to Free Cash Flow
 24.14 24.72 38.15 47.80 167.87
EV to Operating Cash Flow
 16.89 17.40 22.31 27.83 69.32
Tangible Book Value Per Share
 226.55 245.74 207.88 274.13 298.02
Shareholders’ Equity Per Share
 254.15 273.40 232.84 299.26 322.82
Tax and Other Ratios
Effective Tax Rate
 0.24 0.24 0.21 0.25 0.23
Revenue Per Share
 96.07 94.75 90.97 91.45 94.08
Net Income Per Share
 6.26 27.87 -65.36 -21.82 -121.79
Tax Burden
 0.76 0.76 0.79 0.75 0.77
Interest Burden
 -1.81 3.68 1.02 1.06 1.01
Research & Development to Revenue
 0.10 0.10 0.12 0.09 0.09
SG&A to Revenue
 0.33 0.32 0.32 0.00 0.00
Stock-Based Compensation to Revenue
 >-0.01 0.00 0.02 0.02 0.02
Income Quality
 2.07 0.70 -0.25 -0.59 -0.05
Currency in USD